21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia: genes and variants
Explore variant evidence for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia across 1 analyzed protein (CYP21A2). Linked ClinVar records include 37 pathogenic or likely pathogenic variants, 38 variants of uncertain significance and 15 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
CYP21A2: Steroid 21-hydroxylase
It enables cortisol and aldosterone synthesis by 21-hydroxylating adrenal steroid precursors. Biallelic loss-of-function variants cause congenital adrenal hyperplasia, with cortisol deficiency, androgen excess, and in severe forms life-threatening salt wasting.
37 ClinVar pathogenic / likely pathogenic and 52 uncertain variants in CYP21A2 have source records linked to 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CYP19A1.
ClinVar pathogenic and likely pathogenic variants linked to 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CYP21A2 G425S | 425 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 G57R | 57 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R92G | 92 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R427C | 427 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 P31L | 31 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 S114F | 114 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 I237N | 237 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 V238E | 238 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R409C | 409 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 M240K | 240 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R357W | 357 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 M284V | 284 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R342W | 342 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R370W | 370 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 S373N | 373 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 P454S | 454 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 G425V | 425 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 P31S | 31 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 L434P | 434 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 I379N | 379 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 A348T | 348 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 R355C | 355 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 A363V | 363 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 E432K | 432 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 S166C | 166 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 S302Y | 302 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 R340H | 340 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 G431S | 431 | Pathogenic / likely pathogenic | |
| CYP21A2 M261R | 261 | Pathogenic / likely pathogenic | |
| CYP21A2 M261T | 261 | Pathogenic / likely pathogenic | |
| CYP21A2 L52V | 52 | Pathogenic / likely pathogenic | |
| CYP21A2 C170Y | 170 | Pathogenic / likely pathogenic | |
| CYP21A2 R484P | 484 | Pathogenic / likely pathogenic | |
| CYP21A2 G252S | 252 | Pathogenic / likely pathogenic | |
| CYP21A2 V282L | 282 | Pathogenic / likely pathogenic | |
| CYP21A2 P106L | 106 | Pathogenic / likely pathogenic | |
| CYP21A2 L187V | 187 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CYP21A2 R357P | 357 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R357W at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.725 | |
| CYP21A2 R355P | 355 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; R355C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
Which prediction tools work for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 94 out of 100
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 88 out of 100
- ESM1b (LLR): 86 out of 100
- SIFT: 86 out of 100
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 85 out of 100
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Adrenal hyperplasia also has ClinVar records linked to CYP21A2 variants; they fall in the same places as the 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia variants (16 pathogenic / likely pathogenic).
Diseases related to 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
- Adrenal hyperplasia, also linked to CYP21A2
Frequently asked questions
Which genes have records linked to 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia?
This view contains 1 analyzed proteins: CYP21A2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 37 pathogenic or likely pathogenic variants, 38 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 95 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center